HIV-1 infection from cell-to-cell may provide an efficient mode of viral spread in vivo and could therefore present a significant challenge for preventative or therapeutic strategies based on broadly neutralizing antibodies. Indeed, Li et al. (H. Li, C. Zony, P. Chen, and B. K. Chen, J. Virol. 91:e02425-16, 2017, https://doi.org/ 10.1128/JVI.02425-16) showed that the potency and magnitude of multiple HIV-1 broadly neutralizing antibody classes are decreased during cell-to-cell infection in a context-dependent manner. A functional motif in gp41 appears to contribute to this differential susceptibility by modulating exposure of neutralization epitopes.KEYWORDS broadly neutralizing antibody, human immunodeficiency virus, viral envelope, virological synapse T he best-understood process by which HIV-1 mediates infection of susceptible CD4 ϩ target cells is via cell-free virions. Independent virions attach to the target cell membrane, bind CD4 and the coreceptor, mediate membrane fusion at neutral pH, and deposit the nucleocapsid into the new host cell to initiate de novo replication. However, HIV-1 can also mediate infection via virological synapses, where direct cell-to-cell contact between the envelope (Env) glycoprotein gp120 subunit expressed on the infected CD4 ϩ T cell surface interacts with the CD4 receptor on nearby uninfected T cells (reviewed in reference 1). This mode of virus transfer is known as a virological synapse, whereas an immunological synapse mediates transfer from a virus-harboring antigen-presenting cell to an uninfected CD4 ϩ T cell. Cell-to-cell HIV-1 infection was described as early as 1989, including one study that also established the relative levels of resistance of this transmission mode to neutralizing antibody (nAb) and the nucleoside reverse transcriptase inhibitor AZT (2, 3). Cell-to-cell HIV-1 infection has also been estimated to be several orders of magnitude more efficient than cell-free infection (3-6). Although it could represent a predominant mode of viral spread in vivo, cell-tocell transmission has not been studied to the same depth as cell-free infection, as almost all in vitro neutralization assays and in vivo broadly neutralizing antibody (bnAb) protection experiments have been performed using cell-free virus.